These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32012278)

  • 21. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine Excretion Into Human Breast Milk.
    Yazdani-Brojeni P; Tanoshima R; Taguchi N; Garcia-Bournissen F; Wallach I; Moretti ME; Verjee Z; Ito S
    J Clin Psychopharmacol; 2018 Aug; 38(4):362-364. PubMed ID: 29912789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-clinical investigation of the modulation of quetiapine plasma pharmacokinetics and tissues biodistribution by lipid-core nanocapsules.
    Carreño F; Paese K; Silva CM; Guterres SS; Dalla Costa T
    J Pharm Biomed Anal; 2016 Feb; 119():152-8. PubMed ID: 26683988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
    Kopecek M; Potmesil P
    Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal.
    Isbister GK; Friberg LE; Hackett LP; Duffull SB
    Clin Pharmacol Ther; 2007 Jun; 81(6):821-7. PubMed ID: 17410121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
    McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
    J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
    Potkin SG; Preskorn S; Hochfeld M; Meng X
    J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtherapeutic serum quetiapine concentrations after absorption inhibition by binding resins: a case report.
    Hoge RH; Arbouw ME; Radstake SD; van Berlo-van de Laar IR
    J Clin Pharm Ther; 2015 Jun; 40(3):355-7. PubMed ID: 25808008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine Dose Adjustments in Pregnant and Postpartum Women With Bipolar Disorder.
    Pinheiro EA; Wisner KL; Clark CT
    J Clin Psychopharmacol; 2018 Feb; 38(1):89-91. PubMed ID: 29194089
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study.
    Mamo DC; Uchida H; Vitcu I; Barsoum P; Gendron A; Goldstein J; Kapur S
    J Clin Psychiatry; 2008 Jan; 69(1):81-6. PubMed ID: 18312041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a level A in vitro-in vivo correlation for extended release dosage forms of quetiapine fumarate.
    Gonçalves de Lima L; Rossi de Campos D
    Drug Res (Stuttg); 2016 May; 66(5):225-9. PubMed ID: 26697891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.
    Pozzi M; Cattaneo D; Baldelli S; Fucile S; Capuano A; Bravaccio C; Sportiello L; Bertella S; Auricchio F; Bernardini R; Ferrajolo C; Guastella G; Mani E; Carnovale C; Pisano S; Rafaniello C; Riccio MP; Rizzo R; Scuderi MG; Sperandeo S; Villa L; Pascotto A; Molteni M; Rossi F; Radice S; Clementi E
    Eur J Clin Pharmacol; 2016 Mar; 72(3):285-93. PubMed ID: 26613956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dosing of atypical antipsychotics.
    de Leon J; Armstrong SC; Cozza KL
    Psychosomatics; 2005; 46(3):262-73. PubMed ID: 15883149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically-based pharmacokinetics of ziprasidone in pregnant women.
    Biesdorf C; Martins FS; Sy SKB; Diniz A
    Br J Clin Pharmacol; 2019 May; 85(5):914-923. PubMed ID: 30669177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders.
    Jaskiw GE; Thyrum PT; Fuller MA; Arvanitis LA; Yeh C
    Clin Pharmacokinet; 2004; 43(14):1025-35. PubMed ID: 15530131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients.
    Bakken GV; Molden E; Hermann M
    Ther Drug Monit; 2015 Apr; 37(2):256-61. PubMed ID: 25254417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.